EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 183 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,125,000 | -73.1% | 35,700 | -76.0% | 0.09% | -76.7% |
Q2 2016 | $4,184,000 | +22.5% | 148,800 | +58.3% | 0.39% | +13.3% |
Q1 2016 | $3,416,000 | -9.1% | 94,000 | 0.0% | 0.34% | -28.0% |
Q4 2015 | $3,760,000 | +31.3% | 94,000 | -6.5% | 0.48% | +28.8% |
Q3 2015 | $2,863,000 | -13.5% | 100,500 | 0.0% | 0.37% | -19.7% |
Q2 2015 | $3,311,000 | +128.0% | 100,500 | +99.0% | 0.46% | +128.1% |
Q1 2015 | $1,452,000 | +68.8% | 50,500 | +59.8% | 0.20% | +40.0% |
Q4 2014 | $860,000 | +27.8% | 31,600 | 0.0% | 0.14% | +43.6% |
Q3 2014 | $673,000 | -58.7% | 31,600 | -56.5% | 0.10% | -58.3% |
Q2 2014 | $1,630,000 | -49.8% | 72,600 | -43.5% | 0.24% | -52.1% |
Q1 2014 | $3,247,000 | +110.8% | 128,500 | +91.8% | 0.50% | +89.1% |
Q4 2013 | $1,540,000 | +57.9% | 67,000 | +30.9% | 0.27% | +19.7% |
Q3 2013 | $975,000 | +11.7% | 51,200 | -15.5% | 0.22% | -4.7% |
Q2 2013 | $873,000 | – | 60,600 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |